APVO

Aptevo Therapeutics Inc. APVO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode APVO KPRX EPIX HCWB ABP MTNB INAB RADX BCDA CERO
6M -82.68 % -31.43 % -88.02 % -71.19 % -46.48 % -31.00 % 17.73 % 15.51 % -38.05 % -99.48 %
YTD 0.59 % 6.93 % -89.01 % 23.21 % -17.06 % 11.29 % 5.28 % -0.39 % 10.24 % -35.07 %
1Y -99.42 % -38.29 % -89.18 % -90.38 % -91.36 % 24.06 % -70.90 % -0.96 % -33.96 % -99.91 %
3Y -100.00 % -93.65 % -94.05 % -98.43 % -97.98 % -97.55 % -96.28 % -70.91 % -98.66 % -100.00 %
5Y -100.00 % -99.91 % -96.83 % -99.45 % -97.98 % -99.16 % -99.14 % -70.91 % -99.25 % -100.00 %
10Y -100.00 % -99.97 % -99.80 % -99.45 % -97.98 % -98.00 % -99.14 % -70.91 % -99.59 % -100.00 %
From the beginning -100.00 % -99.99 % -99.77 % -99.45 % -97.98 % -98.94 % -99.14 % -70.91 % -100.00 % -100.00 %

Dividend

ESSA Pharma Inc.